Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

9.25
Delayed Data
As of Dec 06
 +0.03 / +0.33%
Today’s Change
5.49
Today|||52-Week Range
9.60
+17.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues27.3M59.7M63.1M60.8M
 
 
 
 
 
Cost of Goods Sold13.3M28.9M30.8M29.2M
 
 
 
 
 
Depreciation And Amortization1.9M5.6M5.4M6.0M
 
 
 
 
 
 
Operating ExpensesGross Income12.1M25.1M27.0M25.5M
 
 
 
 
 
General Expenses17.3M23.2M24.8M24.1M
 
 
 
 
 
Research And Development1.8M1.3M1.3M967.0K
 
 
 
 
 
Total Operating Expenses32.5M57.8M60.9M59.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.2M1.9M2.2M1.4M
 
 
 
 
 
Interest Expense On Debt232.0K1.6M1.4M1.5M
 
 
 
 
 
Other Expenses2.0M0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.4M329.0K745.0K-73.0K
 
 
 
 
 
Income Taxes-2.0M-174.0K-332.0K-6.0K
 
 
 
 
 
Preferred Dividend-122.0K-5.6M-5.6M-5.6M
 
 
 
 
 
Net Income-1.5M155.0K413.0K-67.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS60.9M76.1M77.4M78.1M
 
 
 
 
 
Shares To Calculate EPS Diluted60.9M76.1M77.4M78.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.03-$0.07-$0.07-$0.07
 
 
 
 
 
EPS Diluted-$0.03-$0.07-$0.07-$0.07